Document is current
Any future updates will be listed below
-
Authors
Guffanti, Guia
Kumar, Poornima https://orcid.org/0000-0002-9548-3281
Admon, Roee https://orcid.org/0000-0002-9886-5111
Treadway, Michael T.
Hall, Mei H.
Mehta, Malavika
Douglas, Samuel
Arulpragasam, Amanda R.
Pizzagalli, Diego A. https://orcid.org/0000-0002-7772-1143
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R37 MH068376, R01 MH101521)
- License Information
-
More Information
Article History
Received: 25 March 2019
Revised: 9 July 2019
Accepted: 30 July 2019
First Online: 19 September 2019
Conflict of interest
: Over the past 3 years, D.A.P. has received consulting fees from Akili Interactive Labs, BlackThorn Therapeutics, Boehringer Ingelheim, Compass, Posit Science, and Takeda Pharmaceuticals and an honorarium from Alkermes for activities unrelated to the current review. Dr. Pizzagalli has a financial interest in BlackThorn Therapeutics, which has licensed the copyright to the Probabilistic Reward Task through Harvard University. Dr. Pizzagalli’s interests were reviewed and are managed by McLean Hospital and Partners HealthCare in accordance with their conflict of interest policies. In the past 3 years, Dr. Treadway has served as a paid consultant to BlackThorn Therapeutics, Avanir Pharmaceuticals, and NeuroCog Trials Inc. No funding from these entities was used to support the current work, and all views expressed are solely those of the authors. The remaining authors declare that they have no conflict of interest.
